electroCore (NASDAQ: ECOR)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.070 | -0.080 | -0.0100 | ||||
REV | 1.770M | 1.899M | 129.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of electroCore (NASDAQ: ECOR) through any online brokerage.
Other companies in electroCore’s space includes: Sonendo (NYSE:SONX), Pro-Dex (NASDAQ:PDEX), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for electroCore (NASDAQ: ECOR) was reported by HC Wainwright & Co. on Wednesday, January 19, 2022. The analyst firm set a price target for 2.75 expecting ECOR to rise to within 12 months (a possible 431.40% upside). 2 analyst firms have reported ratings in the last year.
The stock price for electroCore (NASDAQ: ECOR) is $0.5175 last updated Today at July 6, 2022, 1:54 PM UTC.
There are no upcoming dividends for electroCore.
electroCore’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for electroCore.
electroCore is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.